Eltek - ELTK Stock Forecast, Price & News

Eltek's stock was trading at $3.72 at the beginning of the year. Since then, ELTK shares have increased by 9.9% and is now trading at $4.09.
View the best growth stocks for 2022 here.

Eltek saw a increase in short interest in November. As of November 15th, there was short interest totaling 1,600 shares, an increase of 1,500.0% from the October 31st total of 100 shares. Based on an average daily volume of 6,300 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.1% of the company's shares are sold short.
View Eltek's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 22nd 2023.
View our ELTK earnings forecast.

Eltek Ltd. (NASDAQ:ELTK) released its quarterly earnings data on Wednesday, August, 10th. The technology company reported $0.10 earnings per share for the quarter. The technology company had revenue of $9.90 million for the quarter, compared to analysts' expectations of $10.40 million. Eltek had a net margin of 16.09% and a trailing twelve-month return on equity of 29.72%.

Eltek announced a Not Available dividend on Wednesday, November 23rd. Stockholders of record on Monday, December 12th will be paid a dividend of $0.17 per share on Monday, December 19th. This represents a yield of 4.2%. The ex-dividend date of this dividend is Friday, December 9th.
Read our dividend analysis for ELTK.

Eltek's stock reverse split on the morning of Wednesday, November 22nd 2017. The 1-5 reverse split was announced on Wednesday, November 15th 2017. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 21st 2017. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Eltek investors own include Inovio Pharmaceuticals (INO), Allena Pharmaceuticals (ALNA), Energy Transfer (ET), Nokia Oyj (NOK), Pfizer (PFE), Plug Power (PLUG), AbbVie (ABBV), Actinium Pharmaceuticals (ATNM) and Cara Therapeutics (CARA).

Eltek trades on the NASDAQ under the ticker symbol "ELTK."

Eltek's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (1.26%).

Shares of ELTK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ELTK stock can currently be purchased for approximately $4.09.

Eltek (NASDAQ:ELTK) has a market capitalization of $23.93 million and generates $33.82 million in revenue each year. The technology company earns $5.04 million in net income (profit) each year or $1.06 on an earnings per share basis.

The company employs 264 workers across the globe.

Eltek's mailing address is 20 BEN ZION GELIS STREET SGOOLA INDUSTRIAL ZONE, PETACH TIKVA L3, 4927920. The official website for the company is www.nisteceltek.com. The technology company can be reached via phone at (723) 939-5025, via email at cntf@globalirpartners.com, or via fax at 972-3934-2584.